Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from BBH

Biotech ETFs offer investors exposure to the most innovative and growth-oriented industry within the traditionally defensive healthcare sector.

Kiplinger

Brilliant Audi poster has me looking at cars in a whole new way

Just in time for London Fashion Week.

Creative Bloq

Häagen-Dazs’ new billboards give us nothing

And they’re pure perfection

Creative Bloq

From analysis to the latest developments in health,
read the most diverse news in one place.

FTSE 100 thrives but tariff threat hurts Europe

US President Donald Trump on Saturday said major trading partners Mexico and the EU would face a 30% tariff starting next month.

Evening Standard

London's Vagina Museum saved from immediate closure in 'make or break' crowdfunding campaign

The Vagina Museum warned it was just a month away from closing its doors for good due to an impending rent payment

Evening Standard

Ingenious Audi billboards soar above the chaos in EV branding

Tesla and Jaguar could learn a thing.

Creative Bloq

Brown Brothers Harriman’s slavery links exposed by Liverpool campaign

Liverpool Black History Research Group accused America’s oldest private investment bank of sanitising its history

The Guardian - UK

Read news from The Economist, FT, and more,
with one subscription

I love Tesco’s bold logo redesign ads

Produce speaks louder than words.

Creative Bloq

3 Biotech ETFs for a Diversified Portfolio

The biotech industry is growing rapidly with solid advancements, and ETFs in this sector can offer great investment opportunities. Thus, it could be wise to invest in top biotech ETFs SPDR S&P Biotech ETF (XBI), VanEck Biotech ETF (BBH), and iShares Biotechnology ETF (IBB) for a diversified portfolio. Read on.

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Vertex Pharmaceuticals Incorporated

65 stories

the FTSE 100

63 stories

Regeneron Pharmaceuticals

61 stories

Associated British Foods

58 stories

Vertex Pharmaceuticals

56 stories

Regeneron Pharmaceuticals Inc

45 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.